The expanding role of lyso-phosphatidylcholine acyltransferase-3 (LPCAT3), a phospholipid-remodeling enzyme, in health and disease.
Fiche publication
Date publication
février 2022
Journal
Current opinion in lipidology
Auteurs
Membres identifiés du Cancéropôle Est :
Dr LAGROST Laurent, Pr MASSON David
Tous les auteurs :
Lagrost L, Masson D
Lien Pubmed
Résumé
The turnover of fatty acids (FAs) at the sn-2 position of phospholipids is mediated by the reciprocal actions of phospholipases A2 and lyso-PL acyltransferases (LPLAT). LPCAT3, a major LPLAT isoform, exhibits a strong specificity for polyunsaturated FAs s (PUFAs). Although the enzyme was originally studied in the context of cardiometabolism, recent investigations have shed light on the role of LPCAT3 in other tissues such as skeletal muscle and in unexpected biological processes such as cell death and oncogenesis.
Référence
Curr Opin Lipidol. 2022 Feb 14;: